You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Dow
Johnson and Johnson
Express Scripts
Boehringer Ingelheim

Last Updated: September 18, 2020

DrugPatentWatch Database Preview

Litigation Details for Yu v. Apple Inc. (N.D. Cal. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Yu v. Apple Inc. (N.D. Cal. 2018)

Docket   Start Trial Date Filed 2018-10-09
Court District Court, N.D. California Date Terminated
Cause 35:145 Patent Infringement Assigned To James Donato
Jury Demand Plaintiff Referred To
Parties APPLE INC.; YANBIN YU; ZHONGXUAN ZHANG
Patents 10,076,573; 10,285,920; 6,827,946; 6,919,392; 7,018,664; 7,285,289; 7,285,572; 7,572,920; 8,007,793; 8,026,392; 8,101,564; 8,920,392; 9,101,545; 9,907,793; 9,919,024; 9,919,025; 9,919,061
Attorneys Alexandra Marie Stenstedt Leeper; Daniel Johnson , Jr.; Dena Chen; Heidi Lyn Keefe; James Allen Glenn; Lowell D. Mead; Mario Moore; Phillip Edward Morton; Priya Balakrishnan Viswanath; Robert George Litts
Firms Cooley LLP; Dan Johnson Law Group; Phillip Edward Morton
Link to Docket External link to docket
Small Molecule Drugs cited in Yu v. Apple Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Yu v. Apple Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Yu v. Apple Inc. (N.D. Cal. 2018)

Date Filed Document No. Description Snippet Link To Document
2020-03-24 77 Order phones with dual-lens cameras infringe U.S. Patent No. 6,611,289, “Digital Cameras … 10 12(b)(6) motion and patentability under Section 101. Yu, 392 F. Supp. 3d… 6 concept’ sufficient to ‘transform’ the claimed abstract idea into a patent-eligible invention… 6 motions are “disingenuous in view of their own attempts to patent very similar technology… 15 Assoc. v. Dep’t of the Interior, 946 F.3d 564, 582 (9th Cir. 2019). Consequently, the External link to document
2020-05-12 86 Order on Motion for Attorney Fees 18 Pty. Ltd. v. CLS Bank International, 573 U.S. 208 (2014). Yu v. Apple Inc. (Yu I), 392 F. … dual-lens cameras infringed U.S. Patent No. 6,611,289 (“’289 patent”). They filed a virtually … 27 Background about the patent and patentable subject matter are provided in the Court… Dkt. 22 No. 76 in Case No. 18-cv-06339-JD. …the 17 ’289 patent was directed to unpatentable subject matter under External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Moodys
AstraZeneca
Harvard Business School
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.